semaglutide cardioprotective VisualAbstract: Improves Outcomes in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Semaglutide protects against diabetes‐associated cardiac

Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway

Suppresses inappropriate glucagon release, preventing excess hepatic glucose output

GLP-1 receptor agonist use led to a reduction in components of the composite MACE endpoint separately including risk of death from cardiovascular causes, fatal or non-fatal myocardial infarction, and fatal or non-fatal stroke

In the depressive brain, the secretion of diverse neurotransmitters is not stable compared to that in the normal brain

Although stainless steel absorbs odors, any fish remnants left behind can start smelling again

The cost of treating obesity-related complications, including diabetes, cardiovascular disease, joint problems, and certain cancers, far exceeds the cost of effective weight management medication